Diabetes inhibits the DOI-induced head-twitch response in mice

Psychopharmacology

Volumn 177, Issue 1-2, 2004, Pages 224-229

  Miyata, Shigeo ^a   Hirano, Shoko ^a   Kamei, Junzo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Adrenal glands; Corticosterone; Diabetes; Frontal cortex; Head twitch; Hypothalamus; Psychiatric disorders

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; CORTICOSTERONE; SEROTONIN 2A RECEPTOR; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORTICOSTERONE RELEASE; DRUG EFFECT; DRUG RECEPTOR BINDING; FRONTAL CORTEX; HEAD TWITCH; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; MOUSE STRAIN; NERVE CELL NETWORK; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY; SPECIES COMPARISON; STREPTOZOCIN DIABETES;

AMPHETAMINES; ANIMALS; CORTICOSTERONE; DIABETES MELLITUS, EXPERIMENTAL; HEAD MOVEMENTS; KETANSERIN; MALE; MICE; MICE, INBRED ICR; RECEPTOR, SEROTONIN, 5-HT2A;

EID: 12144266207     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-1942-3     Document Type: Article

References (31)

1. Alper RH (1990) Evidence for central and peripheral serotonergic control of corticosterone secretion in the conscious rat. Neuroendocrinology 51:255-260
2. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes. A meta-analysis. Diabetes Care 24:1069-1078
3. 18F]-setoperone during depressive illness and antidepressant treatment with clomipramine. Biol Psychiatry 45:180-186
4. Cameron OG, Kronfol Z, Greden JF, Carroll BJ (1984) Hypothalamic- pituitary-adrenocortical activity in patients with diabetes mellitus. Arch Gen Psychiatry 41:1090-1095
5. Chan O, Chan S, Inouye K, Vranic M, Matthews SG (2001) Molecular regulation of the hypothalamo-pituitary-adrenal axis in streptozotocin-induced diabetes: effects of insulin treatment. Endocrinology 142:4872-4879
6. Chan O, Inouye K, Vranic M, Matthews SG (2002) Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal sensitivity. Endocrinology 143:1761-1768
7. 2 receptors? Pharmacol Biochem Behav 36:901-906
8. 2A receptor are insensitive to many of the behavioral and physiological effects of hallucinogens. Abstr Soc Neurosci 25:799
9. de Groot M, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63:619-630
10. Handley SL, Brown J (1982) Effects on the 5-hydroxytryptamine-induced head-twitch of drugs with selective actions on alpha1 and alpha2-adrenoceptors. Neuropharmacology 21:507-510
11. Handley SL, Singh L (1985) Modulation of 5-hydroxytryptamine-induced head-twitch response by drugs acting at GABA and related receptors. Br J Pharmacol 86:297-303
12. Hosseinzadeh H, Nassiri Asl M (2003) Anticonvulsant, sedative and muscle relaxant effects of carbenoxolone in mice. BMC Pharmacol 3:3
13. 2 recognition sites. Brain Res 376:97-107
14. 2A receptor-mediated behavior in rats after a single footshock. Eur J Pharmacol 452:199-204
15. Kamei J, Ohsawa M (1997) Role of noradrenergic functions in the modification of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes. Life Sci 60:PL223-PL228
16. Kamei J, Ohsawa M (2000) Socio-psychological stress-induced antinociception in diabetic mice. Psychopharmacology 149:397-400
17. Kamei J, Ohhashi Y, Aoki T, Kasuya Y (1991) Streptozotocin-induced diabetes in mice reduces the nociceptive threshold, as recognized after application of noxious mechanical stimuli but not of thermal stimuli. Pharmacol Biochem Behav 39:541-544
18. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE (2000) Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23:934-942
19. McCall AL (1992) The impact of diabetes on the CNS. Diabetes 41:557-570
20. Meltzer HY, Umberkoman-Wiita B, Robertson A, Tricou BJ, Lowy M, Perline R (1984) Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. 1. Enhanced response in depression and mania. Arch Gen Psychiatry 41:366-374
21. 2A receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study. Psychopharmacology 167:72-78
22. Mikuni M, Kusumi I, Kagaya A, Kuroda Y, Mori H, Takahashi K (1991) Increased 5-HT-2 receptor function as measured by serotonin-stimulated phosphoinositide hydrolysis in platelets of depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 15:49-61
23. 1A receptor in the mouse tail suspension test. Neuropsychopharmacology 29:461-469
24. Roy M, Collier B, Roy A (1990) Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients. Psychiatry Res 31:31-37
25. Sakuma T, Honma R, Maguchi S, Tamaki H, Nemoto N (2001) Different expression of hepatic and renal cytochrome P450s between the streptozotocin-induced diabetic mouse and rat. Xenobiotica 31:223-237
26. 1A agonists. J Pharmacol Exp Ther 273:101-112
27. Shapiro ET, Polonsky KS, Copinschi G, Bosson D, Tillil H, Blackman J, Lewis G, Van Cauter E (1991) Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes. J Clin Endocrinol Metab 72:444-454
28. Takao K, Nagatani T, Kitamura Y, Yamawaki S (1997) Effects of corticosterone on 5-HT1A and 5-HT2 receptor binding and on the receptor-mediated behavioral responses of rats. Eur J Pharmacol 333:123-128
29. 2 agonist, (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane. J Pharmacol Exp Ther 270:918-928
30. 2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J Pharmacol Exp Ther 282:699-706
31. 2 receptors in major depression: a positron emission tomography study. Arch Gen Psychiatry 57:850-858